Instituto de Investigación e Innovación en Ciencias Biomédicas (INiBICA)
Instituto de investigación
Hospital Universitario de Jaén
Jaén, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Jaén (10)
2024
-
Whole-genome characterisation of Escherichia coli isolates from patients with bacteraemia presenting with sepsis or septic shock in Spain: a multicentre cross-sectional study
The Lancet Microbe, Vol. 5, Núm. 4, pp. e390-e399
2020
-
Towards the elimination of hepatitis C: Implementation of reflex testing in Andalusia
Revista Espanola de Enfermedades Digestivas, Vol. 112, Núm. 7, pp. 515-519
2016
-
Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain
Journal of Infection, Vol. 72, Núm. 2, pp. 152-160
-
Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome
Critical Care, Vol. 20, Núm. 1
-
Infection in the elderly patient. Consensus recommendations for management in the Emergency Department
Revista Espanola de Geriatria y Gerontologia, Vol. 51, Núm. 2, pp. 120-121
2014
-
Clinical and virological efficacy of etravirine plus two active nucleos(t)ide analogs in an heterogeneous HIV-infected population
PLoS ONE, Vol. 9, Núm. 5
-
Multicentre evaluation of glycated haemoglobin (HbA1c) of Roche Diagnostics in Andalusia
Clinical Biochemistry, Vol. 47, Núm. 12, pp. 1108-1111
-
The role of accessibility policies and other determinants of health care provision in the initial prognosis of malignant melanoma: A cross-sectional study
Journal of the American Academy of Dermatology, Vol. 71, Núm. 3, pp. 507-515
2010
-
Off-label use of rituximab in 196 patients with severe, refractory systemic autoimmune diseases
Clinical and Experimental Rheumatology, Vol. 28, Núm. 4, pp. 468-476
2008
-
Low rate of adverse hepatic events associated with fosamprenavir/ritonavir-based antiretroviral regimens
HIV Clinical Trials, Vol. 9, Núm. 5, pp. 309-313